Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-κB activation and recurrent dexamethasone administration fails to suppress it in vivo.

Saved in:
Bibliographic Details
Title: Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-κB activation and recurrent dexamethasone administration fails to suppress it in vivo.
Authors: Jain S; Tumor Microenvironment and Animal Models Lab, Institute of Life Sciences, Bhubaneswar, Odisha, India.; Manipal Academy of Higher Education, Manipal, Karnataka, India., Dash P; Tumor Microenvironment and Animal Models Lab, Institute of Life Sciences, Bhubaneswar, Odisha, India., Minz AP; Tumor Microenvironment and Animal Models Lab, Institute of Life Sciences, Bhubaneswar, Odisha, India., Satpathi S; Department of Pathology, Ispat General Hospital, Rourkela, Odisha, India., Samal AG; Department of Surgery, Hitech Medical College, Rourkela, Odisha, India., Behera PK; Department of Pathology, Ispat General Hospital, Rourkela, Odisha, India., Satpathi PS; Department of Microbiology, Midnapore Medical College, Midnapore, West Bengal, India., Senapati S; Tumor Microenvironment and Animal Models Lab, Institute of Life Sciences, Bhubaneswar, Odisha, India.
Source: The Prostate [Prostate] 2019 Feb; Vol. 79 (2), pp. 168-182. Date of Electronic Publication: 2018 Sep 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0045
DOI:10.1002/pros.23722